You have access
Histone Deacetylase Inhibitors as a Novel Targeted Therapy Against Non-small Cell Lung Cancer: Where Are We Now and What Should We Expect?
CHRISTOS DAMASKOS, IOANNIS TOMOS, NIKOLAOS GARMPIS, ANNA KARAKATSANI, DIMITRIOS DIMITROULIS, ANNA GARMPI, ELEFTHERIOS SPARTALIS, CHRISTOS F. KAMPOLIS, ELENI TSAGKARI, ANGELIKI A. LOUKERI, GEORGIOS-ANTONIOS MARGONIS, MICHAEL SPARTALIS, NIKOLAOS ANDREATOS, DIMITRIOS SCHIZAS, STEFANIA KOKKINELI, EFSTATHIOS A. ANTONIOU, AFRODITI NONNI, GERASIMOS TSOUROUFLIS, KONSTANTINOS MARKATOS, KONSTANTINOS KONTZOGLOU, ALKIVIADIS KOSTAKIS and PERIKLIS TOMOS
Anticancer Research January 2018, 38 (1) 37-43;
